| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Bioorganic Chemistry (Q1) | ||
| Dergi ISSN | 0045-2068 Dergi Bilgileri (2026) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 10-2026 |
| Cilt / Sayı / Sayfa | 181 / 1 / – | DOI | 10.1016/j.bioorg.2026.110354 |
| Makale Linki | https://doi.org/10.1016/j.bioorg.2026.110354 | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cholinergic dysfunction, making acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) attractive therapeutic targets. In the present study, twelve novel phenolic Mannich base-derived hydrazones incorporating a diaryl ether scaffold were rationally designed, synthesized, and evaluated as cholinesterase inhibitors. All synthesized compounds exhibited potent nanomolar inhibition against both cholinesterases, with K i values ranging from 24.27 to 98.56 nM for AChE and 28.68–148.41 nM for BChE. Compound 5 was identified as the most potent AChE inhibitor ( K i = 24.27 nM), whereas compound 6 showed the highest BChE inhibitory activity ( K i = 28.68 nM). Both compounds were considerably more potent than the reference inhibitors tacrine and donepezil. Enzyme kinetic studies revealed that all … |
| Anahtar Kelimeler |
| Acetylcholinesterase | Alzheimer's disease | Butyrylcholinesterase | Phenolic Mannich bases | SH-SY5Y |
| Atıf Sayıları | |
| Web of Science | 1 |
| Scopus | 1 |
| Google Scholar | 3 |
| Dergi Adı | BIOORGANIC CHEMISTRY |
| Kısa Adı | BIOORG CHEM |
| Yayıncı | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Açık Erişim | Hayır |
| ISSN | 0045-2068 |
| E-ISSN | 1090-2120 |
| Wos Quartile | Q1 |
| Scopus Quartile | Q1 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC |
| Scopus Kategoriler | ORGANIC CHEMISTRY | BIOCHEMISTRY | DRUG DISCOVERY | MOLECULAR BIOLOGY |